GenSight Biologics S.A.
GenSight Biologics S.A. (GSGTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GSGTF · as of Jun 9, 2026
Key Statistics
Explore GenSight Biologics S.A. Data
gsgtf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gsgtf competitorsGSGTF
AGYTF
AVCTF
BJTRF
BOVNF
BPMUFStock Performance
Full HistoryAbout GenSight Biologics S.A.
GenSight Biologics S.A. is a clinical-stage biotechnology firm dedicated to pioneering, advancing, and bringing to market treatments for serious eye and central nervous system disorders, specifically …
what is gensight biologics s.a. · gsgtf stock overview · gensight biologics s.a. company profile · who is gensight biologics s.a. ceo · gsgtf OTC · gensight biologics s.a. headquarters · gensight biologics s.a. business segments
About Stock Overview & Key Data
GenSight Biologics S.A. (GSGTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 22, 2018. As of the latest trading session, GSGTF stock price is $0.19, with a market capitalization of $31.0M. The stock has returned -20.79% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, GenSight Biologics S.A. reported revenue of $999.63. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GenSight Biologics S.A. (GSGTF) stock price is $0.19. The stock is traded on OTC under the ticker symbol GSGTF. The 52-week range is $0.19 – $0.48.